Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Hello Andrea,

We are pleased to invite you to the Koch Institute for Integrative Cancer Research at MIT 2015 Symposium, taking place on 6/12/2015 9:00 AM EDT – 4:30 PM EDT at MIT.   

We expect the available registrations to fill up quickly. So, we would like to offer you the opportunity to reserve your spot at a reduced early bird rate!

Early Bird rates end April 30, 2015, so register today!

For more information, and to RSVP, click here .  

We hope to see you on June 12th!

Sincerely,

Tyler Jacks

Director, Koch Institute for Integrative Cancer Research at MIT

Koch Institute Annual Symposium

CANCER COMPLEXITY:

Heterogeneity in Tumor Progression and Drug Response

Friday, June 12, 2015

9 a.m.-4:30 p.m.

MIT Campus

Johnson Athletics Center, Building W34

Speakers

Michael Hemann, PhD

Symposium Chair

Associate Professor of Biology

Koch Institute at MIT

Christine A. Iacobuzio-Donahue, MD, PhD
Associate Director for Translational Research, David M. Rubenstein Center for Pancreatic Cancer Research

Memorial Sloan Kettering Cancer Center 

Tyler Jacks, PhD
Director

David H. Koch Professor of Biology

Koch Institute at MIT 

Garry P. Nolan, PhD

Rachford and Carlota Harris Professor, Department of Microbiology & Immunology

Stanford University School of Medicine 

Dana Pe’er, PhD

Associate Professor of Biology and Systems Biology

Columbia University 

Kornelia Polyak, MD, PhD

Professor, Department of Medicine, Harvard Medicial School

Department of Medical Oncology, Dana-Farber Cancer Institute 

Alice Shaw, MD, PhD
Associate Professor, Department of Medicine, Harvard Medical School

Thoracic Cancer Program, Massachusetts General Hospital 

Kimberly Stegmaier, MD

Co-Director, Pediatric Hematologic Maligancy Program, Dana-Farber Cancer Institute & Boston Children’s Hospital

Associate Professor of Pediatrics, Harvard Medical School 

Frank Stegmeier, PhD
Director

Novartis Institutes for Biomedical Research

Sir Michael Stratton, PhD

Director

Wellcome Trust Sanger Institute

Charles Swanton, MD, PhD

Professor

Francis Crick Institute and UCL Cancer Institute and Hospitals, UK